MoneyWorks4Me

Beryl Drugs informs about annual report

03 Sep 2021 Evaluate

Beryl Drugs has informed about submission of Annual Report for the Financial Year 2020-21 convening the 28th Annual General Meeting as required under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..